Ibrutinib In Combination With R-Chop In Dlbcl: Does Age Make A Difference

Ibrutinib in combination with R-CHOP in DLBCL: does age make a difference?

VJHemOnc – Video Journal of Hematology & HemOnc

PHOENIX: ibrutinib in combination with R-CHOP for DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Younes on R-CHOP in Combination with Ibrutinib in DLBCL

Ibrutinib in DLBCL: revelations from further analysis of PHOENIX

VJHemOnc – Video Journal of Hematology & HemOnc

The role of ibrutinib in DLBCL and the value of next-generation BTK inhibitors

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. van den Brink Discusses Adding Ibrutinib to R-CHOP in NHL

Phase Ib trial of R-CHOP plus iberdomide or golcadomide in aggressive B-cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Debate: How should patients with ABC type DLBCL be treated today? - R-CHOP

Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor

VJHemOnc – Video Journal of Hematology & HemOnc

Smart Start for newly diagnosed DLBCL: rituximab/lenalidomide/ibrutinib

VJHemOnc – Video Journal of Hematology & HemOnc

Smart Stop: Moving away from R-CHOP in DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Can we add ibrutinib into treatment with R-CHOP in DLBCL?

MMED

What are the Hurdles to Using Cell of Origin in Classification to Treat DLBCL?

iwNHL 2015 roundtable: Day 2 highlights – lenalidomide and ibrutinib for DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Insights into the REMoDL-A trial: acalabrutinib plus R-CHOP for patients with DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Should R-CHOP Remain the Standard of Care for DLBCL?

Dr. Leonard on Ibrutinib Combined With Chemotherapy in Follicular Lymphoma

Tailoring chemotherapy: R-CHOP dose attenuation in elderly DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

DLBCL Which drugs can be combined with R CHOP HD

Recognizing the heterogeneity of DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc